International Stem Cell (ISCO) Receivables - Net (2016 - 2025)
Historic Receivables - Net for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $1.0 million.
- International Stem Cell's Receivables - Net rose 4926.47% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 4926.47%. This contributed to the annual value of $1.1 million for FY2024, which is 8432.06% up from last year.
- According to the latest figures from Q3 2025, International Stem Cell's Receivables - Net is $1.0 million, which was up 4926.47% from $1.1 million recorded in Q2 2025.
- International Stem Cell's 5-year Receivables - Net high stood at $1.1 million for Q2 2025, and its period low was $427000.0 during Q3 2022.
- In the last 5 years, International Stem Cell's Receivables - Net had a median value of $680000.0 in 2024 and averaged $734210.5.
- Data for International Stem Cell's Receivables - Net shows a peak YoY increase of 10942.93% (in 2021) and a maximum YoY decrease of 6159.93% (in 2021) over the last 5 years.
- Over the past 5 years, International Stem Cell's Receivables - Net (Quarter) stood at $844000.0 in 2021, then decreased by 11.49% to $747000.0 in 2022, then dropped by 23.16% to $574000.0 in 2023, then soared by 84.32% to $1.1 million in 2024, then dropped by 4.06% to $1.0 million in 2025.
- Its last three reported values are $1.0 million in Q3 2025, $1.1 million for Q2 2025, and $851000.0 during Q1 2025.